- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03832231
Use of Transient Elastogaphy to Assess Diaphragm Function in Mechanically Ventilated Patients (Elasto-ICU)
Evaluation of Diaphragmatic Function in Mechanically Ventilated Patients With Transient Shear Wave Elastography
Mechanical ventilation is a life-saving treatment that can be associated with diaphragm dysfunction, a potentially deleterious acquired disability. It may be the consequence of disuse - under mechanical ventilation, respiratory muscles are unloaded - or the consequence of muscle overuse because of insufficient unloading. Evaluating diaphragm function is therefore crucial to optimally tailor the ventilator assistance. Measurement of transdiaphragmatic pressure (Pdi) is the reference method to assess diaphragm function but it invasiveness hinders the generalization of its use. Previous studies have reported that ultrasound can quantify diaphragm thickening and that diaphragm thickening fraction (TFdi) is a good marker of diaphragm function. Since diaphragm becomes stiffer when it contracts, the investigators aim at exploring whether the measurement of diaphragm stiffness by transient shear wave elastography would improve the evaluation of diaphragm function with ultrasound.
Therefore, the objectives of the study are to evaluate the performance of transient shear wave elastography applied to the diaphragm to estimate Pdi in mechanically ventilated patients as compared to TFdi and to correlate the changes in elastography derived indices, in TFdi and in Pdi into different ventilatory conditions and during a spontaneous breathing trial. Pdi will be obtained using catheters positioned in patients' stomachs and esophagus and diaphragm stiffness will be assessed by measuring the shear modulus of the diaphragm with a dedicated ultrasound machine (Aixplorer, Ultrasonic). TFdi will be also measured as previously reported. Pdi, TFdi and shear modulus will be measured at the end of each four following 10 minutes-conditions: 1) baseline with initial ventilator settings (set by the physician in charge of patient); 2) 25%-increase in pressure support and initial PEEP; 3) 25%-decrease in pressure support and initial PEEP and 4) initial level of pressure support and ZEEP. Finally, the same measurements will be done at the beginning of a 30 minutes spontaneous breathing trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective :
The main objective is to correlate ultrasound indices (thickness, thickening, rigidity) to the measurement of transdiaphragmatic pressure in the evaluation of the diaphragmatic function of patients under mechanical ventilation.
Secondary objectives are: 1. Correlate thickening of the diaphragm with Pdi, 2. Correlate diaphragmatic thickening with diaphragmatic stiffness 3. Describe these correlations under different levels of pressure ventilatory support, 4. Describe the evolution of diaphragmatic stiffness, thickening and Pdi pressure during a ventilator liberating trial.
The primary endpoint is the measurement of Pdi. The secondary endpoints are the diaphragm thickening fraction and diaphragm stiffness.
Methods :
The Pdi will be obtained by measuring the esophageal and gastric pressures through nasogastric tube equipped with balloons. The position of each of the balloons will be checked by displaying the esophageal and gastric pressure lines. The intragastric position will be confirmed by mild abdominal compression. The oesophageal position is based on visualization of cardiac artifacts on the pressure pattern and signal deflations related to inspiratory movements. The signals of the esophageal and gastric pressures will be displayed continuously and their resultant - transdiapragmatic pressure - will be automatically calculated in real time by the software. It will also record pressure in the airways at the endotracheal tube.
Patients will be placed in half-sitting position to allow better recognition of the diaphragm. Using the ultrasound system Aixplorer® (Aix en Provence, France V9), equipped with a high resolution probe (6 MHz). The probe will be positioned at the intercostal space above the tenth rib on the right axillary line and directed perpendicular to the diaphragm (apposition zone). The measurements will be performed "offline" and the calculation of the thickening fraction will be performed in blind clinical conditions.
The diaphragmatic elastography will be determined using the same ultrasound system (Aixplorer®, Aix en Provence, France V9, provided with a high resolution probe (SL10-2, central frequency, 6 MHz)). The anatomical approach is the same as the intercostal approach described previously. After finding the diaphragm in B mode, a transition to SWE (elastography) mode will be performed. Three successive measurements will be made on the same region of interest, the average of the three measurements will be retained. The variation of the shear modulus during the inspiratory time will also be calculated post hoc. As for standard ultrasound, records analysis will be performed in blind conditions.
Pdi, ultrasound derived indices and shear wave modulus will be measured under several conditions.
- At baseline: initial ventilator settings set by the physician in charge of patient
- 25%-increase in pressure support and initial PEEP during 10 minutes
- 25%-decrease in pressure support and initial PEEP during 10 minutes
- initial level of pressure support without PEEP (PEEP = 0) during 10 minutes
- Measurement of the maximal inspiratory pressure during an inspiratory occlusion maneuver lasting 20 seconds.
- A 30 minutes Ventilator liberating trial without PEEP nor Pressure Support (CPAP=0)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75013
- Groupe Hospitalier Pitie-Salpetriere
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
All patients receiving mechanical ventilation and having spontaneous efforts will be eligible if they meet the following criteria:
Inclusion criteria
- Age ≥ 18 years old
- Intubation and mechanical ventilation since 24 hours
- Failure to a first ventilator liberating trial
- nasogastric feeding tube in place
- readiness criteria to undertake a ventilator liberating trial (Boles et al. ERJ 2007)
- patient written consent or next of kin written consent in case of physical inability of the patient to sign the consent form
- french social Health Service registration
Exclusion criteria
- pregnancy
- protective administrative control
- patient's refusal
- contra indications to the insertion of esophageal and gastric balloons
- allergy to topical anesthetic
- impossible weaning (full dependance to mechanical ventilation)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Ventilator liberating trial
The diaphragmatic function of patients undergoing a ventilator liberating trial will be determined with transient shear wave elastography.
|
Ultrasound technology to assess tissue stiffness
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in transdiaphragmatic pressure
Time Frame: Through patient participation, an average of 1 day
|
Reference method to assess diaphragm function computed as the difference between esophageal pressure and gastric pressure
|
Through patient participation, an average of 1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in diaphragm thickness and thickening as expressed by the thickening fraction (ratio of the difference between inspiratory and expiratory thickness over expiratory thickness).
Time Frame: Through patient participation, an average of 1 day
|
Using the ultrasound system Aixplorer® (Aix en Provence, France V9), equipped with a high resolution probe (6 MHz), anatomical structures will be identify using B-mode.
A switch to TM-mode will allow us to measure the thickening fraction.
A second switch to shear wave elastography allows to identify an elastography map of the diaphragm and calculate an average of the shear wave modulus.
|
Through patient participation, an average of 1 day
|
|
Change in diaphragm stiffness
Time Frame: Through patient participation, an average of 1 day
|
Using the ultrasound system Aixplorer® (Aix en Provence, France V9), equipped with a high resolution probe (6 MHz), anatomical structures will be identify using B-mode.
A switch to TM-mode will allow us to measure the thickening fraction.
A second switch to shear wave elastography allows to identify an elastography map of the diaphragm and calculate an average of the shear wave modulus.
|
Through patient participation, an average of 1 day
|
|
Success or failure at the spontaneous breathing trial
Time Frame: Through patient participation, an average of 1 day
|
Presence of clinical intolerance criteria according to Boles et al.
ERJ 20107
|
Through patient participation, an average of 1 day
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- APHP180264
- 2018-A02311-54 (OTHER: ANSM)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intensive Care Unit
-
Indiana UniversityIndiana University HealthRecruitingPost Intensive Care Unit Syndrome | Intensive Care Unit Delirium | Intensive Care Acquired Cognitive Impairment | Virtual Reality Cognitive TrainingUnited States
-
University of MelbourneEnrolling by invitationICU Acquired Weakness | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit Syndrome | Post Intensive Care SyndromeAustralia
-
Seoul National University HospitalMinistry of Food and Drug Safety, KoreaCompletedPostoperative Care | Intensive Care UnitKorea, Republic of
-
Nantes University HospitalCompleted
-
Centre Hospitalier Régional d'OrléansCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedIntensive Care UnitTurkey
-
First People's Hospital of ChenzhouRecruiting
-
Wuhan Union Hospital, ChinaCompletedIntensive Care UnitChina
-
Hospira, now a wholly owned subsidiary of PfizerCompleted
Clinical Trials on Shear Wave Elastography
-
Istanbul UniversityCompletedAdenomyosis | Elastography | Transvaginal Ultrasound | Fibroid UterusTurkey
-
Mayo ClinicRecruitingRespiratory Complication | Respiratory Function LossUnited States
-
Vejle HospitalCompletedRectal Neoplasms | Elasticity Imaging TechniquesDenmark
-
Ramzy Raafat Mohamed Mohamed Elnabarawy, MD, MSc...Cairo UniversityCompletedTo Investigate the Value of Penile Elastography in the Diagnosis of Fibrosis of CCEgypt
-
University of DundeeCompleted
-
Istanbul UniversityCompleted
-
Fábio FernandesPfizerUnknown
-
Fatih Sultan Mehmet Training and Research HospitalCompletedTendon Injuries | Muscle Weakness | Anterior Cruciate Ligament RuptureTurkey (Türkiye)
-
Assiut UniversityNot yet recruiting